Related Experiment Video
Updated: Jun 13, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
[Body composition and polycystic ovary syndrome]
Lina Zabuliene1, Janina Tutkuviene
1Department of Anatomy, Histology and Anthropology, Faculty of Medicine, Vilnius University, M. K. Ciurlionio 21/27, Vilnius, Lithuania.
Medicina (Kaunas, Lithuania)
|May 5, 2010
Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women. Research suggests body composition and sexual dimorphism may help predict PCOS development and outcomes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Reproductive Health
Background:
- Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting reproductive-aged women.
- Key features include hyperandrogenism, menstrual dysfunction, infertility, and obesity.
- Diagnostic criteria lack universal consensus, complicating clinical identification.
Purpose of the Study:
- To explore correlations between PCOS phenotypic expression, body composition, and sexual maturation.
- To investigate the relationship between PCOS and environmental factors like nutrition and physical activity.
- To enhance understanding of PCOS development and prognosis by considering individual and environmental influences.
Main Methods:
- Analysis of existing literature on PCOS, body composition, and sexual dimorphism.
- Review of studies examining morphological and physiological indices in relation to PCOS.
- Focus on body size, shape, fat distribution, and specific sexual dimorphism markers like the 2D:4D ratio.
Main Results:
- Women with PCOS exhibit increased adipose tissue, particularly abdominal and upper arm fat.
- Elevated waist circumference and waist-to-hip ratio in PCOS correlate with poorer reproductive and metabolic health.
- The 2D:4D digit ratio is one of the few sexual dimorphism indices studied in relation to PCOS.
Conclusions:
- Body composition and sexual dimorphism markers may offer insights into PCOS.
- Early identification of physical status changes could aid in predicting PCOS metabolic characteristics and outcomes.
- Further research is needed to fully understand the interplay of individual and environmental factors in PCOS.
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...